1. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. (4th November 2015) Authors: Mace, Thomas; Shakya, Reena; Pitarresi, Jason; Loftus, Shannon; Swanson, Benjamin; Young, Gregory; Zhong, Xioling; Zimmers, Teresa; Ostrowski, Michael; Ludwig, Thomas; Bloomston, Mark; Bekaii-Saab, Tanios; Lesinski, Gregory Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Issue 2 (December 2015) Authors: Mace, Thomas; Shakya, Reena; Pitarresi, Jason; Loftus, Shannon; Swanson, Benjamin; Young, Gregory; Zhong, Xioling; Zimmers, Teresa; Ostrowski, Michael; Ludwig, Thomas; Bloomston, Mark; Bekaii-Saab, Tanios; Lesinski, Gregory Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗